APO Research
Talk to an analyst

APO RESEARCH · REPORT

3 Phosphoinositide Dependent Protein Kinase 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global 3 Phosphoinositide Dependent Protein Kinase 1 Industry Growth and Trends Forecast to 2032

19 December 202574 pages

Choose your research edition.

Industry Research3 Phosphoinositide Dependent Protein Kinase 1 Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal 3 Phosphoinositide Dependent Protein Kinase 1 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global 3 Phosphoinositide Dependent Protein Kinase 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 3 Phosphoinositide Dependent Protein Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 3 Phosphoinositide Dependent Protein Kinase 1 include Tolero Pharmaceuticals, Inc., Sunesis Pharmaceuticals, Inc. and Arno Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global 3 Phosphoinositide Dependent Protein Kinase 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The 3 Phosphoinositide Dependent Protein Kinase 1 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 3 Phosphoinositide Dependent Protein Kinase 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 3 Phosphoinositide Dependent Protein Kinase 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global 3 Phosphoinositide Dependent Protein Kinase 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

3 Phosphoinositide Dependent Protein Kinase 1 Market by Company

Tolero Pharmaceuticals, Inc.

Sunesis Pharmaceuticals, Inc.

Arno Therapeutics, Inc.

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Type

SNS-229

PHT-427

HCI-1708

AR-12

Others

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Application

Clinic

Hospital

Others

3 Phosphoinositide Dependent Protein Kinase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3 Phosphoinositide Dependent Protein Kinase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 3 Phosphoinositide Dependent Protein Kinase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3 Phosphoinositide Dependent Protein Kinase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 3 Phosphoinositide Dependent Protein Kinase 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of 3 Phosphoinositide Dependent Protein Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of SNS-229 Table 2. Major Company of PHT-427 Table 3. Major Company of HCI-1708 Table 4. Major Company of AR-12 Table 5. Major Company of Others Table 6. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (K Units) Table 8. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Type (2021-2026) Table 9. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 10. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Type (2021-2026) Table 11. Global 3 Phosphoinositide Dependent Protein Kinase 1 Price by Type (2021-2026) & (US$/Unit) Table 12. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2027-2032) & (K Units) Table 13. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Type (2027-2032) Table 14. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2027-2032) & (US$ Million) Table 15. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Type (2027-2032) Table 16. Global 3 Phosphoinositide Dependent Protein Kinase 1 Price by Type (2027-2032) & (US$/Unit) Table 17. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (K Units) Table 18. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (K Units) Table 20. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (K Units) Table 24. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 27. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Trends Table 28. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Drivers Table 29. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Opportunities and Challenges Table 30. 3 Phosphoinositide Dependent Protein Kinase 1 Industry Restraints Table 31. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global 3 Phosphoinositide Dependent Protein Kinase 1 Revenue Market Share by Company (2021-2026) Table 33. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Company (2021-2026) & (K Units) Table 34. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Share by Company (2021-2026) Table 35. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global 3 Phosphoinositide Dependent Protein Kinase 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global 3 Phosphoinositide Dependent Protein Kinase 1 Major Company Production Sites and Headquarters Table 38. Global 3 Phosphoinositide Dependent Protein Kinase 1 Company, Product Type & Application Table 39. Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global 3 Phosphoinositide Dependent Protein Kinase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2021-2026) & (K Units) Table 44. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Region (2021-2026) Table 45. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2021-2026) & (US$ Million) Table 46. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Region (2021-2026) Table 47. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2027-2032) & (K Units) Table 49. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Region (2027-2032) Table 50. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Region (2027-2032) & (US$ Million) Table 51. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Region (2027-2032) Table 52. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (K Units) Table 55. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Application (2021-2026) Table 56. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 57. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Application (2021-2026) Table 58. Global 3 Phosphoinositide Dependent Protein Kinase 1 Price by Application (2021-2026) & (US$/Unit) Table 59. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2027-2032) & (K Units) Table 60. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Application (2027-2032) Table 61. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2027-2032) & (US$ Million) Table 62. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Application (2027-2032) Table 63. Global 3 Phosphoinositide Dependent Protein Kinase 1 Price by Application (2027-2032) & (US$/Unit) Table 64. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (K Units) Table 65. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (K Units) Table 67. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (K Units) Table 71. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 74. Tolero Pharmaceuticals, Inc. Company Information Table 75. Tolero Pharmaceuticals, Inc. Business Overview Table 76. Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 78. Tolero Pharmaceuticals, Inc. Recent Development Table 79. Sunesis Pharmaceuticals, Inc. Company Information Table 80. Sunesis Pharmaceuticals, Inc. Business Overview Table 81. Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 83. Sunesis Pharmaceuticals, Inc. Recent Development Table 84. Arno Therapeutics, Inc. Company Information Table 85. Arno Therapeutics, Inc. Business Overview Table 86. Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio Table 88. Arno Therapeutics, Inc. Recent Development Table 89. North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 90. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 91. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 92. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 93. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 94. North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 95. North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 96. North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country (2021-2026) Table 97. North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 98. North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 99. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 101. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 102. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 103. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 104. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 106. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country (2021-2026) Table 107. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 109. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 111. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 112. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 113. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 116. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country (2021-2026) Table 117. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 119. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 121. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 122. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 123. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 124. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 126. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country (2021-2026) Table 127. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 129. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026) & (K Units) Table 131. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share by Country (2021-2026) Table 132. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 133. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country (2021-2026) Table 137. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Share Forecast by Country (2027-2032) Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. 3 Phosphoinositide Dependent Protein Kinase 1 Distributors List Table 142. 3 Phosphoinositide Dependent Protein Kinase 1 Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. 3 Phosphoinositide Dependent Protein Kinase 1 Image Figure 2. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales (2021-2032) & (K Units) Figure 5. SNS-229 Image Figure 6. Global SNS-229 Sales YoY Growth (2021-2032) & (K Units) Figure 7. PHT-427 Image Figure 8. Global PHT-427 Sales YoY Growth (2021-2032) & (K Units) Figure 9. HCI-1708 Image Figure 10. Global HCI-1708 Sales YoY Growth (2021-2032) & (K Units) Figure 11. AR-12 Image Figure 12. Global AR-12 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Type 2025 VS 2032 Figure 17. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 18. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 19. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 20. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 23. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 3 Phosphoinositide Dependent Protein Kinase 1 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Application 2025 VS 2032 Figure 37. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 38. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 39. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 40. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 43. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Market Share in Value by Application in 2025 Figure 47. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. 3 Phosphoinositide Dependent Protein Kinase 1 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. 3 Phosphoinositide Dependent Protein Kinase 1 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • SNS-229
  • PHT-427
  • HCI-1708
  • AR-12
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Tolero Pharmaceuticals, Inc.
  • Sunesis Pharmaceuticals, Inc.
  • Arno Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 3 Phosphoinositide Dependent Protein Kinase 1 Market by Type
  6. 1.3.1 SNS-229
  7. 1.3.2 PHT-427
  8. 1.3.3 HCI-1708
  9. 1.3.4 AR-12
  10. 1.3.5 Others
  11. 1.4 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Type
  12. 1.4.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 3 Phosphoinositide Dependent Protein Kinase 1 Industry Trends
  2. 2.2 3 Phosphoinositide Dependent Protein Kinase 1 Industry Drivers
  3. 2.3 3 Phosphoinositide Dependent Protein Kinase 1 Industry Opportunities and Challenges
  4. 2.4 3 Phosphoinositide Dependent Protein Kinase 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by 3 Phosphoinositide Dependent Protein Kinase 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by 3 Phosphoinositide Dependent Protein Kinase 1 Sales (2021-2026)
  3. 3.3 Global Top Players by 3 Phosphoinositide Dependent Protein Kinase 1 Price (2021-2026)
  4. 3.4 Global 3 Phosphoinositide Dependent Protein Kinase 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 3 Phosphoinositide Dependent Protein Kinase 1 Major Company Production Sites & Headquarters
  6. 3.6 Global 3 Phosphoinositide Dependent Protein Kinase 1 Company, Product Type & Application
  7. 3.7 Global 3 Phosphoinositide Dependent Protein Kinase 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 3 Phosphoinositide Dependent Protein Kinase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 3 Phosphoinositide Dependent Protein Kinase 1 Tier 1, Tier 2, and Tier 3
4 3 Phosphoinositide Dependent Protein Kinase 1 Regional Status and Outlook
  1. 4.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Historic Market Size by Region
  3. 4.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Forecasted Market Size by Region
  7. 4.3.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 3 Phosphoinositide Dependent Protein Kinase 1 by Application
  1. 5.1 3 Phosphoinositide Dependent Protein Kinase 1 Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Application
  6. 5.2.1 Global 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global 3 Phosphoinositide Dependent Protein Kinase 1 Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global 3 Phosphoinositide Dependent Protein Kinase 1 Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tolero Pharmaceuticals, Inc.
  2. 6.1.1 Tolero Pharmaceuticals, Inc. Company Information
  3. 6.1.2 Tolero Pharmaceuticals, Inc. Business Overview
  4. 6.1.3 Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tolero Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  6. 6.1.5 Tolero Pharmaceuticals, Inc. Recent Developments
  7. 6.2 Sunesis Pharmaceuticals, Inc.
  8. 6.2.1 Sunesis Pharmaceuticals, Inc. Company Information
  9. 6.2.2 Sunesis Pharmaceuticals, Inc. Business Overview
  10. 6.2.3 Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sunesis Pharmaceuticals, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  12. 6.2.5 Sunesis Pharmaceuticals, Inc. Recent Developments
  13. 6.3 Arno Therapeutics, Inc.
  14. 6.3.1 Arno Therapeutics, Inc. Company Information
  15. 6.3.2 Arno Therapeutics, Inc. Business Overview
  16. 6.3.3 Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Arno Therapeutics, Inc. 3 Phosphoinositide Dependent Protein Kinase 1 Product Portfolio
  18. 6.3.5 Arno Therapeutics, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country
  2. 7.1.1 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026)
  4. 7.1.3 North America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country
  6. 7.2.1 North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country
  2. 8.1.1 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country
  6. 8.2.1 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country
  2. 9.1.1 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country
  6. 9.2.1 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country
  2. 10.1.1 South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026)
  4. 10.1.3 South America 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country
  6. 10.2.1 South America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country
  2. 11.1.1 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country
  6. 11.2.1 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa 3 Phosphoinositide Dependent Protein Kinase 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 3 Phosphoinositide Dependent Protein Kinase 1 Value Chain Analysis
  2. 12.1.1 3 Phosphoinositide Dependent Protein Kinase 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 3 Phosphoinositide Dependent Protein Kinase 1 Production Mode & Process
  7. 12.2 3 Phosphoinositide Dependent Protein Kinase 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 3 Phosphoinositide Dependent Protein Kinase 1 Distributors
  10. 12.2.3 3 Phosphoinositide Dependent Protein Kinase 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst